Production of high titer attenuated poliovirus strains on the serum-free PER.C6® cell culture platform for the generation of safe and affordable next generation IPV
Highlights • PER.C6® cells are susceptible to infection with attenuated poliovirus strains. • Sabin strains in PER.C6® cells show increased productivity as compared to Vero cells. • Sabin strain productivity in PER.C6® cells was maintained during infection at 10 l scale. • Rationally-attenuated stra...
Gespeichert in:
Veröffentlicht in: | Vaccine 2015-11, Vol.33 (48), p.6611-6616 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6616 |
---|---|
container_issue | 48 |
container_start_page | 6611 |
container_title | Vaccine |
container_volume | 33 |
creator | Sanders, Barbara P Oakes, Isabel de los Rios van Hoek, Vladimir Liu, Ying Marissen, Wilfred Minor, Philip D Wimmer, Eckard Schuitemaker, Hanneke Custers, Jerome H.H.V Macadam, Andrew Cello, Jeronimo Edo-Matas, Diana |
description | Highlights • PER.C6® cells are susceptible to infection with attenuated poliovirus strains. • Sabin strains in PER.C6® cells show increased productivity as compared to Vero cells. • Sabin strain productivity in PER.C6® cells was maintained during infection at 10 l scale. • Rationally-attenuated strains demonstrated high yields on the PER.C6® platform. |
doi_str_mv | 10.1016/j.vaccine.2015.10.091 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1749611718</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X15015479</els_id><sourcerecordid>1749611718</sourcerecordid><originalsourceid>FETCH-LOGICAL-c495t-bb5677fb8baffd2d36988cd8b255b114eb1b6211cc8dba28c704ad37956516ae3</originalsourceid><addsrcrecordid>eNqFkk2O1DAQhSMEYpqBI4AssWGT4EpiJ9mAUGuAkUaixZ_YWf6pTLtJOz2202IOxJZDcDIcugfQbNjYUul7r1x-lWWPgRZAgT_fFHuptXVYlBRYqhW0gzvZAtqmyksG7d1sQUte5zXQLyfZgxA2lFJWQXc_Oyk5KzvK20X2feVHM-loR0fGnqzt5ZpEG9ETGSO6SUY0ZDcOdtxbPwUSopfWBZLwuEYS0E_bvPeIZHX2vljynz-IxmEgehri5JHsBhn70W9JOn4rLtGhlzf9guyRSGeI7BNgpBqQOPwW_8XOV58fZvd6OQR8dLxPs0-vzz4u3-YX796cL19d5LruWMyVYrxpetWqZGdKU_GubbVpVcmYAqhRgeIlgNatUbJsdUNraaqmY5wBl1idZs8Ovjs_Xk0YotjaMM8jHY5TENDUHQdooE3o01voZpy8S69LFKsa3jUMEsUOlPZjCB57sfN2K_21ACrmHMVGHHMUc45zOeWYdE-O7pPaovmjugkuAS8PAKbv2Fv0ImiLTqOxHnUUZrT_bfHiloMerLNaDl_xGsPfaUQoBRUf5mWadwlYMqmbrvoF3ybJbQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1753769751</pqid></control><display><type>article</type><title>Production of high titer attenuated poliovirus strains on the serum-free PER.C6® cell culture platform for the generation of safe and affordable next generation IPV</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central UK/Ireland</source><creator>Sanders, Barbara P ; Oakes, Isabel de los Rios ; van Hoek, Vladimir ; Liu, Ying ; Marissen, Wilfred ; Minor, Philip D ; Wimmer, Eckard ; Schuitemaker, Hanneke ; Custers, Jerome H.H.V ; Macadam, Andrew ; Cello, Jeronimo ; Edo-Matas, Diana</creator><creatorcontrib>Sanders, Barbara P ; Oakes, Isabel de los Rios ; van Hoek, Vladimir ; Liu, Ying ; Marissen, Wilfred ; Minor, Philip D ; Wimmer, Eckard ; Schuitemaker, Hanneke ; Custers, Jerome H.H.V ; Macadam, Andrew ; Cello, Jeronimo ; Edo-Matas, Diana</creatorcontrib><description>Highlights • PER.C6® cells are susceptible to infection with attenuated poliovirus strains. • Sabin strains in PER.C6® cells show increased productivity as compared to Vero cells. • Sabin strain productivity in PER.C6® cells was maintained during infection at 10 l scale. • Rationally-attenuated strains demonstrated high yields on the PER.C6® platform.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2015.10.091</identifier><identifier>PMID: 26529068</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Allergy and Immunology ; Animals ; Antibodies, Viral - blood ; Cell Culture Techniques ; Cell Line ; Cercopithecus aethiops ; Culture Media, Serum-Free - chemistry ; Enzyme-Linked Immunosorbent Assay ; Manufacturing ; Mutation ; Next generation IPV ; PER.C6® cells ; Poliomyelitis ; Poliomyelitis - prevention & control ; Poliovirus ; Poliovirus - genetics ; Poliovirus - growth & development ; Poliovirus Vaccine, Inactivated - immunology ; Poliovirus Vaccine, Oral ; Rabbits ; Rationally-attenuated strains ; Sabin ; Vaccines ; Vaccines, Attenuated ; Vero Cells ; Viral Load ; Virus Cultivation - methods</subject><ispartof>Vaccine, 2015-11, Vol.33 (48), p.6611-6616</ispartof><rights>Elsevier Ltd</rights><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Nov 27, 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c495t-bb5677fb8baffd2d36988cd8b255b114eb1b6211cc8dba28c704ad37956516ae3</citedby><cites>FETCH-LOGICAL-c495t-bb5677fb8baffd2d36988cd8b255b114eb1b6211cc8dba28c704ad37956516ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1753769751?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26529068$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sanders, Barbara P</creatorcontrib><creatorcontrib>Oakes, Isabel de los Rios</creatorcontrib><creatorcontrib>van Hoek, Vladimir</creatorcontrib><creatorcontrib>Liu, Ying</creatorcontrib><creatorcontrib>Marissen, Wilfred</creatorcontrib><creatorcontrib>Minor, Philip D</creatorcontrib><creatorcontrib>Wimmer, Eckard</creatorcontrib><creatorcontrib>Schuitemaker, Hanneke</creatorcontrib><creatorcontrib>Custers, Jerome H.H.V</creatorcontrib><creatorcontrib>Macadam, Andrew</creatorcontrib><creatorcontrib>Cello, Jeronimo</creatorcontrib><creatorcontrib>Edo-Matas, Diana</creatorcontrib><title>Production of high titer attenuated poliovirus strains on the serum-free PER.C6® cell culture platform for the generation of safe and affordable next generation IPV</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Highlights • PER.C6® cells are susceptible to infection with attenuated poliovirus strains. • Sabin strains in PER.C6® cells show increased productivity as compared to Vero cells. • Sabin strain productivity in PER.C6® cells was maintained during infection at 10 l scale. • Rationally-attenuated strains demonstrated high yields on the PER.C6® platform.</description><subject>Allergy and Immunology</subject><subject>Animals</subject><subject>Antibodies, Viral - blood</subject><subject>Cell Culture Techniques</subject><subject>Cell Line</subject><subject>Cercopithecus aethiops</subject><subject>Culture Media, Serum-Free - chemistry</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Manufacturing</subject><subject>Mutation</subject><subject>Next generation IPV</subject><subject>PER.C6® cells</subject><subject>Poliomyelitis</subject><subject>Poliomyelitis - prevention & control</subject><subject>Poliovirus</subject><subject>Poliovirus - genetics</subject><subject>Poliovirus - growth & development</subject><subject>Poliovirus Vaccine, Inactivated - immunology</subject><subject>Poliovirus Vaccine, Oral</subject><subject>Rabbits</subject><subject>Rationally-attenuated strains</subject><subject>Sabin</subject><subject>Vaccines</subject><subject>Vaccines, Attenuated</subject><subject>Vero Cells</subject><subject>Viral Load</subject><subject>Virus Cultivation - methods</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkk2O1DAQhSMEYpqBI4AssWGT4EpiJ9mAUGuAkUaixZ_YWf6pTLtJOz2202IOxJZDcDIcugfQbNjYUul7r1x-lWWPgRZAgT_fFHuptXVYlBRYqhW0gzvZAtqmyksG7d1sQUte5zXQLyfZgxA2lFJWQXc_Oyk5KzvK20X2feVHM-loR0fGnqzt5ZpEG9ETGSO6SUY0ZDcOdtxbPwUSopfWBZLwuEYS0E_bvPeIZHX2vljynz-IxmEgehri5JHsBhn70W9JOn4rLtGhlzf9guyRSGeI7BNgpBqQOPwW_8XOV58fZvd6OQR8dLxPs0-vzz4u3-YX796cL19d5LruWMyVYrxpetWqZGdKU_GubbVpVcmYAqhRgeIlgNatUbJsdUNraaqmY5wBl1idZs8Ovjs_Xk0YotjaMM8jHY5TENDUHQdooE3o01voZpy8S69LFKsa3jUMEsUOlPZjCB57sfN2K_21ACrmHMVGHHMUc45zOeWYdE-O7pPaovmjugkuAS8PAKbv2Fv0ImiLTqOxHnUUZrT_bfHiloMerLNaDl_xGsPfaUQoBRUf5mWadwlYMqmbrvoF3ybJbQ</recordid><startdate>20151127</startdate><enddate>20151127</enddate><creator>Sanders, Barbara P</creator><creator>Oakes, Isabel de los Rios</creator><creator>van Hoek, Vladimir</creator><creator>Liu, Ying</creator><creator>Marissen, Wilfred</creator><creator>Minor, Philip D</creator><creator>Wimmer, Eckard</creator><creator>Schuitemaker, Hanneke</creator><creator>Custers, Jerome H.H.V</creator><creator>Macadam, Andrew</creator><creator>Cello, Jeronimo</creator><creator>Edo-Matas, Diana</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20151127</creationdate><title>Production of high titer attenuated poliovirus strains on the serum-free PER.C6® cell culture platform for the generation of safe and affordable next generation IPV</title><author>Sanders, Barbara P ; Oakes, Isabel de los Rios ; van Hoek, Vladimir ; Liu, Ying ; Marissen, Wilfred ; Minor, Philip D ; Wimmer, Eckard ; Schuitemaker, Hanneke ; Custers, Jerome H.H.V ; Macadam, Andrew ; Cello, Jeronimo ; Edo-Matas, Diana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c495t-bb5677fb8baffd2d36988cd8b255b114eb1b6211cc8dba28c704ad37956516ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Allergy and Immunology</topic><topic>Animals</topic><topic>Antibodies, Viral - blood</topic><topic>Cell Culture Techniques</topic><topic>Cell Line</topic><topic>Cercopithecus aethiops</topic><topic>Culture Media, Serum-Free - chemistry</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Manufacturing</topic><topic>Mutation</topic><topic>Next generation IPV</topic><topic>PER.C6® cells</topic><topic>Poliomyelitis</topic><topic>Poliomyelitis - prevention & control</topic><topic>Poliovirus</topic><topic>Poliovirus - genetics</topic><topic>Poliovirus - growth & development</topic><topic>Poliovirus Vaccine, Inactivated - immunology</topic><topic>Poliovirus Vaccine, Oral</topic><topic>Rabbits</topic><topic>Rationally-attenuated strains</topic><topic>Sabin</topic><topic>Vaccines</topic><topic>Vaccines, Attenuated</topic><topic>Vero Cells</topic><topic>Viral Load</topic><topic>Virus Cultivation - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sanders, Barbara P</creatorcontrib><creatorcontrib>Oakes, Isabel de los Rios</creatorcontrib><creatorcontrib>van Hoek, Vladimir</creatorcontrib><creatorcontrib>Liu, Ying</creatorcontrib><creatorcontrib>Marissen, Wilfred</creatorcontrib><creatorcontrib>Minor, Philip D</creatorcontrib><creatorcontrib>Wimmer, Eckard</creatorcontrib><creatorcontrib>Schuitemaker, Hanneke</creatorcontrib><creatorcontrib>Custers, Jerome H.H.V</creatorcontrib><creatorcontrib>Macadam, Andrew</creatorcontrib><creatorcontrib>Cello, Jeronimo</creatorcontrib><creatorcontrib>Edo-Matas, Diana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sanders, Barbara P</au><au>Oakes, Isabel de los Rios</au><au>van Hoek, Vladimir</au><au>Liu, Ying</au><au>Marissen, Wilfred</au><au>Minor, Philip D</au><au>Wimmer, Eckard</au><au>Schuitemaker, Hanneke</au><au>Custers, Jerome H.H.V</au><au>Macadam, Andrew</au><au>Cello, Jeronimo</au><au>Edo-Matas, Diana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Production of high titer attenuated poliovirus strains on the serum-free PER.C6® cell culture platform for the generation of safe and affordable next generation IPV</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2015-11-27</date><risdate>2015</risdate><volume>33</volume><issue>48</issue><spage>6611</spage><epage>6616</epage><pages>6611-6616</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Highlights • PER.C6® cells are susceptible to infection with attenuated poliovirus strains. • Sabin strains in PER.C6® cells show increased productivity as compared to Vero cells. • Sabin strain productivity in PER.C6® cells was maintained during infection at 10 l scale. • Rationally-attenuated strains demonstrated high yields on the PER.C6® platform.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>26529068</pmid><doi>10.1016/j.vaccine.2015.10.091</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2015-11, Vol.33 (48), p.6611-6616 |
issn | 0264-410X 1873-2518 |
language | eng |
recordid | cdi_proquest_miscellaneous_1749611718 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete; ProQuest Central UK/Ireland |
subjects | Allergy and Immunology Animals Antibodies, Viral - blood Cell Culture Techniques Cell Line Cercopithecus aethiops Culture Media, Serum-Free - chemistry Enzyme-Linked Immunosorbent Assay Manufacturing Mutation Next generation IPV PER.C6® cells Poliomyelitis Poliomyelitis - prevention & control Poliovirus Poliovirus - genetics Poliovirus - growth & development Poliovirus Vaccine, Inactivated - immunology Poliovirus Vaccine, Oral Rabbits Rationally-attenuated strains Sabin Vaccines Vaccines, Attenuated Vero Cells Viral Load Virus Cultivation - methods |
title | Production of high titer attenuated poliovirus strains on the serum-free PER.C6® cell culture platform for the generation of safe and affordable next generation IPV |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T21%3A20%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Production%20of%20high%20titer%20attenuated%20poliovirus%20strains%20on%20the%20serum-free%20PER.C6%C2%AE%20cell%20culture%20platform%20for%20the%20generation%20of%20safe%20and%20affordable%20next%20generation%20IPV&rft.jtitle=Vaccine&rft.au=Sanders,%20Barbara%20P&rft.date=2015-11-27&rft.volume=33&rft.issue=48&rft.spage=6611&rft.epage=6616&rft.pages=6611-6616&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2015.10.091&rft_dat=%3Cproquest_cross%3E1749611718%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1753769751&rft_id=info:pmid/26529068&rft_els_id=S0264410X15015479&rfr_iscdi=true |